GeneDx Holdings Corp. (WGS) Capital expenditures 2019–2025
GeneDx Holdings Corp. (WGS) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$19.0MFY2025 · since FY2019: $11.9M → $19.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $19.0M | +246.3% |
| FY2024 | $5.5M | +4.6% |
| FY2023 | $5.3M | -26.6% |
| FY2022 | $7.2M | -23.9% |
| FY2021 | $9.4M | -61.0% |
| FY2020 | $24.1M | +102.1% |
| FY2019 | $11.9M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice